Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure

Vikas Bhatia; Navkaranbir S. Bajaj; Kumar Sanam; Taimoor Hashim; Charity J. Morgan; Sumanth D. Prabhu; Gregg C. Fonarow; Prakash Deedwania; Javed Butler; Peter Carson; Thomas E. Love; Raya Kheirbek; Wilbert S. Aronow; Stefan D. Anker; Finn Waagstein; Ross Fletcher; Richard M. Allman; Ali Ahmed

doi:10.1016/j.amjmed.2014.11.036

Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure

Vikas Bhatia, Navkaranbir S. Bajaj, Kumar Sanam, Taimoor Hashim, Charity J. Morgan, Sumanth D. Prabhu, Gregg C. Fonarow, Prakash Deedwania, Javed Butler, Peter Carson, Thomas E. Love, Raya Kheirbek, Wilbert S. Aronow, Stefan D. Anker, Finn Waagstein, Ross Fletcher, Richard M. Allman, Ali Ahmed

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Abstract

Background Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable Care Act. Methods Of the 3067 Medicare beneficiaries discharged alive from 106 Alabama hospitals (1998-2001) with a primary discharge diagnosis of heart failure and ejection fraction

Original language	English
Pages (from-to)	715-721
Number of pages	7
Journal	American Journal of Medicine
Volume	128
Issue number	7
DOIs	https://doi.org/10.1016/j.amjmed.2014.11.036
Publication status	Published - Jul 1 2015

Keywords

Beta-blockers
Hospitalization
Older adults
Readmission
Systolic heart failure

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/j.amjmed.2014.11.036

Cite this

Bhatia, V., Bajaj, N. S., Sanam, K., Hashim, T., Morgan, C. J., Prabhu, S. D., Fonarow, G. C., Deedwania, P., Butler, J., Carson, P., Love, T. E., Kheirbek, R., Aronow, W. S., Anker, S. D., Waagstein, F., Fletcher, R., Allman, R. M., & Ahmed, A. (2015). Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure. American Journal of Medicine, 128(7), 715-721. https://doi.org/10.1016/j.amjmed.2014.11.036

Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure. / Bhatia, Vikas; Bajaj, Navkaranbir S.; Sanam, Kumar; Hashim, Taimoor; Morgan, Charity J.; Prabhu, Sumanth D.; Fonarow, Gregg C.; Deedwania, Prakash; Butler, Javed; Carson, Peter; Love, Thomas E.; Kheirbek, Raya; Aronow, Wilbert S.; Anker, Stefan D.; Waagstein, Finn; Fletcher, Ross; Allman, Richard M.; Ahmed, Ali.

In: American Journal of Medicine, Vol. 128, No. 7, 01.07.2015, p. 715-721.

Research output: Contribution to journal › Article › peer-review

Bhatia, V, Bajaj, NS, Sanam, K, Hashim, T, Morgan, CJ, Prabhu, SD, Fonarow, GC, Deedwania, P, Butler, J, Carson, P, Love, TE, Kheirbek, R, Aronow, WS, Anker, SD, Waagstein, F, Fletcher, R, Allman, RM & Ahmed, A 2015, 'Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure', American Journal of Medicine, vol. 128, no. 7, pp. 715-721. https://doi.org/10.1016/j.amjmed.2014.11.036

Bhatia, Vikas ; Bajaj, Navkaranbir S. ; Sanam, Kumar ; Hashim, Taimoor ; Morgan, Charity J. ; Prabhu, Sumanth D. ; Fonarow, Gregg C. ; Deedwania, Prakash ; Butler, Javed ; Carson, Peter ; Love, Thomas E. ; Kheirbek, Raya ; Aronow, Wilbert S. ; Anker, Stefan D. ; Waagstein, Finn ; Fletcher, Ross ; Allman, Richard M. ; Ahmed, Ali. / Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure. In: American Journal of Medicine. 2015 ; Vol. 128, No. 7. pp. 715-721.

@article{6545baf5c48746fca52ee08124a15411,

title = "Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure",

abstract = "Background Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable Care Act. Methods Of the 3067 Medicare beneficiaries discharged alive from 106 Alabama hospitals (1998-2001) with a primary discharge diagnosis of heart failure and ejection fraction ",

keywords = "Beta-blockers, Hospitalization, Older adults, Readmission, Systolic heart failure",

author = "Vikas Bhatia and Bajaj, {Navkaranbir S.} and Kumar Sanam and Taimoor Hashim and Morgan, {Charity J.} and Prabhu, {Sumanth D.} and Fonarow, {Gregg C.} and Prakash Deedwania and Javed Butler and Peter Carson and Love, {Thomas E.} and Raya Kheirbek and Aronow, {Wilbert S.} and Anker, {Stefan D.} and Finn Waagstein and Ross Fletcher and Allman, {Richard M.} and Ali Ahmed",

year = "2015",

month = jul,

day = "1",

doi = "10.1016/j.amjmed.2014.11.036",

language = "English",

volume = "128",

pages = "715--721",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure

AU - Bhatia, Vikas

AU - Bajaj, Navkaranbir S.

AU - Sanam, Kumar

AU - Hashim, Taimoor

AU - Morgan, Charity J.

AU - Prabhu, Sumanth D.

AU - Fonarow, Gregg C.

AU - Deedwania, Prakash

AU - Butler, Javed

AU - Carson, Peter

AU - Love, Thomas E.

AU - Kheirbek, Raya

AU - Aronow, Wilbert S.

AU - Anker, Stefan D.

AU - Waagstein, Finn

AU - Fletcher, Ross

AU - Allman, Richard M.

AU - Ahmed, Ali

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable Care Act. Methods Of the 3067 Medicare beneficiaries discharged alive from 106 Alabama hospitals (1998-2001) with a primary discharge diagnosis of heart failure and ejection fraction

AB - Background Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable Care Act. Methods Of the 3067 Medicare beneficiaries discharged alive from 106 Alabama hospitals (1998-2001) with a primary discharge diagnosis of heart failure and ejection fraction

KW - Beta-blockers

KW - Hospitalization

KW - Older adults

KW - Readmission

KW - Systolic heart failure

UR - http://www.scopus.com/inward/record.url?scp=84931091490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931091490&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2014.11.036

DO - 10.1016/j.amjmed.2014.11.036

M3 - Article

C2 - 25554369

AN - SCOPUS:84931091490

VL - 128

SP - 715

EP - 721

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 7

ER -

Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this